We hypothesized that the prophylactic administration of ADSCs prior to the onset of NEC in a rat model would reduce the levels of pro-inflammatory cytokines IL-1 and IL-6, compared to the NEC group treated with saline. The gene discussed is IL1A; the disease is necrotizing enterocolitis.